Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,998 | 1,026 | 19.07. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
12.06. | Nanoform Finland Oyj: Nanoform starts Pivotal Human Bioequivalence Studies of Nanoenzalutamide | 531 | GlobeNewswire (Europe) | Nanoform Finland Plc | Press Release | June 12, 2025 at 08:10:00 EEST
HELSINKI, FINLAND, June 12, 2025 - Nanoform Finland Plc, the medicine performance-enhancing company, today announced that it had... ► Artikel lesen | |
20.05. | Nanoform Finland Oyj: Nanoform Q1 2025 report: Deal mosaic emerge and commercial value clearly seen in our CESS technology | 721 | GlobeNewswire (Europe) | Nanoform Finland Plc | Company Release | May 20, 2025 at 08:10:00 EEST
Term sheets agreed for several key markets around nanoenzalutamide1). First term sheet also signed around nanoencorafenib2). Negotiations... ► Artikel lesen | |
15.04. | Nanoform Finland Oyj: Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc | 579 | GlobeNewswire (Europe) | Company release
Nanoform Finland Plc
April 15, 2025
14.10 Finnish time / 13.10 Swedish time
Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc
Nanoform Finland... ► Artikel lesen | |
15.04. | Resolutions of Nanoform Finland Plc's Annual General Meeting on April 15, 2025 | 2 | Cision News | ||
17.03. | Notice to the Annual General Meeting of NANOFORM FINLAND Plc | 4 | Cision News | ||
27.02. | Nanoform Finland Oyj: Nanoform 2024 report: Deal discussions around product kernels intensify | 1.060 | GlobeNewswire (Europe) | Company Announcement
Nanoform Finland Plc
February 27, 2025
08:10 a.m. Finnish time / 07:10 a.m. Swedish time
Nanoform 2024 report: Deal discussions around product kernels intensify
After a strong... ► Artikel lesen | |
13.02. | Invitation to Nanoform's Q4 and FY 2024 Report Presentation | 2 | Cision News | ||
18.11.24 | Nanoform Finland Oyj: Nanoform Q3 2024 report: Record number of new projects signed | 985 | GlobeNewswire (Europe) | Company Announcement
Nanoform Finland Plc
November 18, 2024
08:10 a.m. Finnish time / 07:10 a.m. Swedish time
Nanoform Q3 2024 report: Record number of new projects signed
A record number of new... ► Artikel lesen | |
NANOFORM FINLAND Aktie jetzt für 0€ handeln | |||||
15.08.24 | NANOFORM COLLABORATES WITH TAKEDA ON THEIR PLASMA-DERIVED THERAPY DEVELOPMENT | 1.251 | PR Newswire | HELSINKI, Aug. 15, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, today announced that it is to enter into a pre-clinical development... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FORMYCON | 29,650 | +0,17 % | EQS-AFR: Formycon AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Formycon AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Formycon AG: Vorabbekanntmachung über die Veröffentlichung... ► Artikel lesen | |
KOPIN | 1,811 | -2,79 % | Kopin Corp Trending Amid Recent ESG Framework Announcement, Stock Spikes 6.7% After Hours | ||
GAUZY | 6,970 | -2,52 % | Gauzy Ltd. Sets Date for Second Quarter 2025 Results | ||
ONTO INNOVATION | 83,50 | 0,00 % | Benchmark bestätigt Kaufempfehlung für Onto Innovation | ||
SOLESENCE | 4,040 | -1,22 % | Solésence, Inc.: Solésence Announces Uplisting to Nasdaq | Trading set to begin Tuesday, April 8 under new ticker "SLSN" ROMEOVILLE, Ill., April 07, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions... ► Artikel lesen | |
VEECO INSTRUMENTS | 18,800 | +1,62 % | University of Michigan synthesizes high-quality 2D molybdenum disulfide using Veeco's Fiji ALD system | ||
OBDUCAT | 0,060 | +50,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025 | Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY... ► Artikel lesen | |
FENDX TECHNOLOGIES | 0,045 | -7,41 % | FendX Technologies Inc.: FendX Provides Corporate Update | Vancouver, British Columbia--(Newsfile Corp. - July 18, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), an innovative surface protection company using... ► Artikel lesen | |
DOTZ NANO | 0,023 | +4,55 % | XFRA 57N: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
ZENTEK | 0,740 | -2,63 % | Zentek Ltd. - 6-K, Report of foreign issuer | ||
NANOVIRICIDES | 1,420 | -0,70 % | WHO Extended Global Emergency Status of MPox Epidemic - Development of Treatment for MPox with NV-387 is Timely, Says NanoViricides | SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development... ► Artikel lesen | |
NVE | 68,50 | -0,72 % | Dividendenbekanntmachungen (19.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AFFILIATED MANAGERS GROUP INC US0082521081 0,01 USD 0,0089 EUR AIR LIQUIDE SA FR0000120073 - 3,3 EUR ALA SPA IT0005446700 - 0,75... ► Artikel lesen | |
ACACIA RESEARCH | 3,160 | 0,00 % | ACACIA RESEARCH CORP - 8-K, Current Report | ||
ADVANCE ZINCTEK | 0,525 | +7,58 % | ADVANCE ZINCTEK LIMITED: Update on Tariffs Announced by Trump Administration Today | ||
LAMPETIA | 0,042 | -16,00 % | EQS-News: LEHNER INVESTMENTS AG: Jahresabschluss 2024 mit positivem Ergebnis | EQS-News: LEHNER INVESTMENTS AG
/ Schlagwort(e): Jahresergebnis
LEHNER INVESTMENTS AG: Jahresabschluss 2024 mit positivem Ergebnis
30.06.2025 / 16:18 CET/CEST
Für den... ► Artikel lesen |